A recent New York Times story described a new fad: "microdosing" GLP-1 anti-obesity drugs like semaglutide (Ozempic, Wegovy) ...

Soon it will be the new year, which means new year’s resolutions — and a very common one is weight loss. People on social ...

Biotech leader says additional research into existing medications, drug classes, and mechanisms of action can bring forth ...

Elon Musk, one of President-elect Donald Trump’s closest confidants, revealed Wednesday his support for weight-loss drugs ...

Sharon Osbourne expresses frustration after manipulated photos of her dramatic weight loss from Ozempic circulate on ...

Serena Williams' recent slimmed-down appearance amid her weight-loss journey has led to fan speculation about the tennis ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

Lottie Moss recently discussed the devastating effects of using Ozempic. However, it seems she has managed to get back in ...

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...